Top 10 Heal Care Stocks To Own Right Now


WiLAN (NASDAQ:WILN) manages the intellectual property of third party inventors to ensure they receive fair compensation for their investment in research and development. By enabling patent owners to sell or license patented intellectual property, WiLAN helps provide a financial incentive for inventors to invest in the development of new technologies.

WiLAN has gone through several difficult years brought-on by the combination of the AIA (see below), some legal missteps, and just plain bad luck. In response, WiLAN has adapted by taking advantage of the fire-sale on patents to expand its portfolio, and has started to exercise its property rights in foreign jurisdictions. An interesting example is the litigation against SONY in Nanjing China and in Germany.


More than 290 companies have taken licenses with WiLAN, and there are more than 50 on-notice and in various stages of litigation. With the increased support for property rites, that we expect from Trump, the positive resolution of this litigation becomes increasingly likely.

Top 10 Heal Care Stocks To Own Right Now: Gordmans Stores, Inc.(GMAN)

Advisors’ Opinion:

  • [By WWW.THESTREET.COM]

    Just in the past few weeks, Wall Street has seen bankruptcy filings from sporting goods retailer Gander Mountain, RadioShack successor General Wireless Operations, everyday value price department store operator Gordmans Stores (GMAN) and appliances, electronics and furniture retailer HHGregg (HGG) . Last Wednesday, children’s apparel retailer Gymboree cautioned it was running low on cash and may not survive. Sears Holdings Corp. (SHLD) voiced concerns on Tuesday about its ability to stay in business, while women’s apparel chain Bebe (BEBE) is reportedly on the brink of closing all 170 of its stores.

  • [By Peter Graham]

    A long term performance chart shows Five Below at least remaining in positive territory while off-price or value price retailer peerlarge capRoss Stores, Inc (NASDAQ: ROST) has outperformed for a few years and small capGordmans Stores, Inc (NASDAQ: GMAN) has severelyunderperformed:

Top 10 Heal Care Stocks To Own Right Now: Novo Nordisk A/S(NVO)

Advisors’ Opinion:

  • [By Brian Orelli]

    Global Blood Therapeutics (NASDAQ:GBT) is up 20% at 3:42 p.m. EST after Reuters reported that Novo Nordisk (NYSE:NVO) has approached the biotech about a potential acquisition.

  • [By James E. Brumley]

    When most investors think of diabetes stocks, names like Novo Nordisk A/S (ADR) (NYSE:NVO) and MannKind Corporation (NASDAQ:MNKD) come to mind. And well they should. Novo Nordisk is the biggest insulin company in the world, and while MannKind is relatively small, it’s a name that turns heads simply because it came up with an inhalable insulin that – after a slow start – is getting a little traction.


    In both cases though, the paradigm is the same one that was first used decades ago. That is, if a person isn’t making their own insulin, then it must be introduced externally. What if instead a diabetic’s glucose levels could be controlled by turning on the cells in their body responsible for processing that sugar? That’s the approach Cell MedX Corp (OTCMKTS:CMXC) is taking, using a relatively new but very compelling science.

    While chemical-based manufactured pharmaceuticals were largely the core of healthcare for well over the past century, it’s become clear that our bodies – right down to our cells – are also electrical in nature. Not only do they produce it, they need it to function properly. The FDA has even recently approved a therapeutic device that delivers mild electrical currents to and through an individual’s body as a means of treating pain. This “electromedicine” has also shown a certain degree of efficacy as a treatment for several illnesses, including cancer. Specifically, electrical currents have been demonstrated to force pleomorphic cancer microbes into hibernation, essentially making a cancerous cell a normal, healthy cell again. So, using an electrical current as a means of therapy for diabetics isn’t far-fetched at all. Indeed, it’s quite brilliant.


    As for how Cell MedX is using the idea, it’s actually quite simple. The device is called an eBalance. At first glance it just looks like another ordinary tablet computer. A closer inspection of the e-Balance device, however, makes it clear that it’s not just another tablet. It’

  • [By Paul Ausick]

    Novo Nordisk A/S (NYSE: NVO) dropped about 1.5% on Friday to post a new 52-week low of $32.35 after closing at $32.84 on Thursday. The stock’s 52-week high is $59.00. Volume of about 3.4 million was close to the daily average of around 3.9 million shares. The drug maker had no specific news.

Top 10 Heal Care Stocks To Own Right Now: Teva Pharmaceutical Industries Limited(TEVA)


Advisors’ Opinion:

  • [By Ben Levisohn]

    Teva Pharmaceutical Industries (TEVA) slashed its earnings guidance today and told investors that in 2017, it would be “focused on execution.” Of course, I’ve never heard a company tell investors that, hey, we’re not really going to focus on executing this year, but what do I know? I’m just a blogger. Maxim’s Gabrielle Zhou and team try to explain what Teva means:

    Getty Images


    Teva provided an updated business outlook for 2017. The company expects to continue its execution on the integration of the Actavis transaction. However, Teva reduced full year 2017 guidance…Net revenues are now estimated in a range of $23.8B-$24.5B, non-GAAP EPS is $4.90-$5.30 (based on weighted average shares of 1,076M). Recall that Teva provided a 2016-2019 preliminary financial outlook in July 2016 that included projected 2017 revenues of $25.2B-$26.2B and non-GAAP EPS of $6.00-$6.50; reduced guidance reflects delays in the timing of generic launches (some by a year), price erosion and external competition.


    Conclusion: we downgrade the stock to Hold from Buy. Teva is working to realize synergies from the Actavis business integration, launch new products in 2017, and generate free cash flow to the company, but challenges in the near term to the core generic and specialty business are becoming bigger issues. We will have to wait and see the company refocus on developing its organic growth. As such, we are downgrading the stock to Hold from Buy and lowering the price target to $41 from $49

    Shares of Teva Pharmaceutical Industries dropped 7.5% to $35.11 at 3:18 p.m. today.

  • [By Paul Ausick]

    Teva Pharmaceutical Industries Ltd. (NYSE: TEVA) posted a new 52-week low of $31.90 on Wednesday, down about 0.7% compared with Tuesday’s closing price of $32.14. The stock’s 52-week high is $58.16. Volume was about 65% below the daily average of around 9.7 million shares. The company had no specific news.

  • [By Paul Ausick]

    Teva Pharmaceutical Industries Ltd. (NYSE: TEVA) dropped about 4% Tuesday to post a new 52-week low of $30.86 after closing at $32.15 on Monday. The stock’s 52-week high is $58.16. Volume was about 10% below the daily average of around 9.3 million shares. The company had no specific news.

  • [By WWW.MONEYSHOW.COM]

    Opioid drug abuse has become a national epidemic; Teva Pharmaceutical Industries Limited (TEVA) has just developed a drug that could potentially deliver pain relief without the scourge of addiction, suggests Jimmy Mengel, editor of The Crow’s Nest.

Top 10 Heal Care Stocks To Own Right Now: Affimed N.V.(AFMD)

Advisors’ Opinion:

  • [By Lisa Levin]

    Shares of Affimed NV (NASDAQ: AFMD) were down around 21 percent to $1.70. Affimed priced its public offering of 10,000,000 of its common shares at $1.80 per common share.

Top 10 Heal Care Stocks To Own Right Now: Formula Systems (1985) Ltd.(FORTY)


Advisors’ Opinion:

  • [By Lisa Levin]

    In trading on Thursday, technology shares fell by 0.32 percent. Meanwhile, top losers in the sector included Mitek Systems, Inc. (NASDAQ: MITK), down 13 percent, and Formula Systems (1985) Ltd. (ADR) (NASDAQ: FORTY), down 8 percent.

  • [By Lisa Levin]

    On Friday, technology shares rose by 0.26 percent. Meanwhile, top gainers in the sector included Applied Materials, Inc. (NASDAQ: AMAT), up 9 percent, and Formula Systems (1985) Ltd. (ADR) (NASDAQ: FORTY) up 19 percent.

Top 10 Heal Care Stocks To Own Right Now: Bioanalytical Systems, Inc.(BASI)


Advisors’ Opinion:

  • [By Alex McGuire]

    Here’s a list of the top 10 penny stocks to watch in March, which includes the biggest gainers last month…

    Penny StockCurrent Stock PriceFebruary 2017 ReturnZosano Pharma Corp. (Nasdaq: ZSAN)$2.56+123.3%Bellerophon Therapeutics Inc. (Nasdaq: BLPH)$1.25+113.8%Peregrine Pharmaceuticals (Nasdaq: PPHM)$0.59+101.7%Galectin Therapeutics Inc. (Nasdaq: GALT)$1.79+91.9%Bioanalytical Systems Inc. (Nasdaq: BASI)$1.58+90.6%CymaBay Therapeutics Inc. (Nasdaq: CBAY)$3.50+89.8%Vermillion Inc. (Nasdaq: VRML)$2.56+86.3%Naked Brand Group Inc.(Nasdaq:NAKD)$2.16+76%Eyegate Pharmaceuticals Inc. (Nasdaq: EYEG)$2.63+73.9%Benitec Biopharma Ltd. (Nasdaq ADR: BNTC)$2.60+59.9%


    The best-performing penny stock – Zosano Pharma Corp. – soared an incredible 123.3% from Feb. 1 to Feb. 28. To put those gains into perspective, that’s more than five times the S&P 500’s 23% climb in the last 12 months.

  • [By Lisa Levin] Related SOFO 12 Biggest Mid-Day Losers For Tuesday Earnings Scheduled For December 10, 2015 Related WSCI 15 Biggest Mid-Day Losers For Wednesday Earnings Scheduled For June 21, 2016 Companies Reporting Before The Bell Rite Aid Corporation (NYSE: RAD) is projected to report its quarterly earnings at $0.04 per share on revenue of $8.23 billion. Conagra Brands Inc (NYSE: CAG) is estimated to report its quarterly earnings at $0.45 per share on revenue of $2.11 billion. Bioanalytical Systems, Inc. (NASDAQ: BASI) is expected to report earnings for the fourth quarter.

     

Top 10 Heal Care Stocks To Own Right Now: Ritchie Bros. Auctioneers Incorporated(RBA)

Advisors’ Opinion:

  • [By Benzinga News Desk]

    Raymond James has downgraded Ritchie Bros. Auctioneers Inc (USA) (NYSE: RBA) common stock to Market Perform

    Loop Capital's Betsy Van Hees sees storage, networking, and connectivity as the 3 reasons why Marvell Technology Group Ltd. (NASDAQ: MRVL) will return to top-Line growth. She reiterated her Buy rating and $18 price target. 

Top 10 Heal Care Stocks To Own Right Now: Pure Cycle Corporation(PCYO)

Advisors’ Opinion:

  • [By Jim Robertson]

    On Wednesday, our Under the Radar Moversnewsletter suggested small cap water and wastewater services stockPure Cycle Corporation (NASDAQ: PCYO) as a long/bullish trade:

Top 10 Heal Care Stocks To Own Right Now: Coffee Holding Co., Inc.(JVA)

Advisors’ Opinion:

  • [By Peter Graham]

    A long term performance chart for Farmer Brothers Co shows an outstanding outperformance while large capStarbucks Corporation has been flat for more than a year and both iPath Bloomberg Coffee Subindex Total Return SM Index ETN and small cap Coffee Holding Co, Inc (NASDAQ: JVA) have underperformed:

Top 10 Heal Care Stocks To Own Right Now: Ascent Capital Group, Inc.(ASCMA)

Advisors’ Opinion:

  • [By Ian Wyatt, Publisher & Chief Investment Strategist, Wyatt Investment Research]

    Both of these stocks are overlooked, undervalued, and cash flow machines. The companies are Ascent Capital Group (ASCMA) and Covanta Holdings (CVA).

Leave a Reply

Your email address will not be published. Required fields are marked *